Skip to main content
Signal8

VSEE HEALTH, INC. (VSEE) Form 10-Q — Nov 16, 2026

$VSEEForm 10-QFiled Nov 16, 2026, 5:35 PM ET0001185185-26-005491Original filing

VSee Health filed its Q3 2026 10-Q with revenue of $4.94 million for the nine months (up from $4.57 million), but a Q3 loss from continuing operations of $2.85 million versus only $42,456 a year earlier. Cash ended the period at just $41,666 against $9.6 million in current liabilities, and management explicitly raised substantial doubt about the company's ability to continue as a going concern. The company executed a 1-for-80 reverse stock split on September 22, 2026, a dilutive last-resort measure typically tied to listing/price compliance. Multiple legacy notes payable remain in default for late payment, with default interest rates of up to 26% per annum accruing on several.

Key figures

Eps
-6.83
Revenue
4937956
Total Debt
1813998
Revenue Yoy
9-month revenue up from $4,571,727 in prior-year period
Total Assets
15706172
Cash Position
41666
Q3 revenue
1496779
Accumulated deficit
87018413
Reverse split ratio
1:80
Shares outstanding nov15 2026
876837
Gain on sale of discontinued ops
4168878

AI analysis

Red flags6 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.

    VSEE HEALTH, INC. (VSEE) Form 10-Q — Nov 16, 2026: AI Analysis | Signal8